0001213900-20-017429.txt : 20200714 0001213900-20-017429.hdr.sgml : 20200714 20200714160415 ACCESSION NUMBER: 0001213900-20-017429 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200714 DATE AS OF CHANGE: 20200714 EFFECTIVENESS DATE: 20200714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kitov Pharma Ltd. CENTRAL INDEX KEY: 0001614744 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-370984 FILM NUMBER: 201027226 BUSINESS ADDRESS: STREET 1: ONE AZRIELI CENTER, ROUND TOWER STREET 2: 132 MENACHEM BEGIN ROAD CITY: TEL AVIV STATE: L3 ZIP: 6701101 BUSINESS PHONE: 97239333121 MAIL ADDRESS: STREET 1: ONE AZRIELI CENTER, ROUND TOWER STREET 2: 132 MENACHEM BEGIN ROAD CITY: TEL AVIV STATE: L3 ZIP: 6701101 FORMER COMPANY: FORMER CONFORMED NAME: Kitov Pharmaceuticals Holdings Ltd. DATE OF NAME CHANGE: 20140724 D 1 primary_doc.xml X0708 D LIVE 0001614744 Kitov Pharma Ltd. ONE AZRIELI CENTER, ROUND TOWER 132 MENACHEM BEGIN ROAD TEL AVIV L3 ISRAEL 6701101 97239333121 ISRAEL Mainrom Line Logistics Ltd. Kitov Pharmaceuticals Holdings Ltd. Other Limited company true Isaac Israel One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Director Chief Executive Officer and Director of the Issuer Eric Rowinsky One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director and Chairman of the Board of Directors of the Issuer Simcha Rock One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Director of the Issuer Steven Steinberg One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director of the Issuer Ido Agmon One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director of the Issuer Ran Tzror One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director of the Issuer Revital Stern-Raff One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director of the Issuer Hadas Reuveni One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer VP R&D of the Issuer Gil Efron One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Deputy CEO and Chief Financial Officer of the Issuer Bertrand Liang One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Chief Medical Officer of the Issuer Michael Schickler One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Head of Clinical Operations of the Issuer Pharmaceuticals Decline to Disclose 06b false 2020-05-24 false true false 0 NONE None None None NONE NONE NONE XX Unknown 00000 NY NEW YORK false Indefinite 0 Indefinite Private placements of 812,500 of Filer's ADSs previously issued in June 2020, and 486,111 of Filer's ADSs to be issued in July 2020 to a former placement agent as part of a tail fee in connection with Filer's 2020 offerings. false 1 0 0 0 See clarification to item 13 above. false Kitov Pharma Ltd. /s/ Gil Efron Gil Efron Deputy CEO and Chief Financial Officer 2020-07-14